Reporting the early stage clinical evaluation of virtual-reality-based intervention trials: RATE-VR

Johan H. Vlake; Jasper van Bommel; Giuseppe Riva; Brenda K. Wiederhold; Pietro Cipresso; Albert Skip Rizzo; Cristina Botella; Lotty Hooft; O. Joseph Bienvenu; Bart Geerts; Evert Jan Wils; Diederik Gommers; Michel E. van Genderen

doi:10.1038/s41591-022-02085-7

Reporting the early stage clinical evaluation of virtual-reality-based intervention trials: RATE-VR

Johan H. Vlake, Jasper van Bommel, Giuseppe Riva, Brenda K. Wiederhold, Pietro Cipresso, Albert Skip Rizzo, Cristina Botella, Lotty Hooft, O. Joseph Bienvenu, Bart Geerts, Evert Jan Wils, Diederik Gommers, Michel E. van Genderen

School of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	12-13
Number of pages	2
Journal	Nature medicine
Volume	29
Issue number	1
DOIs	https://doi.org/10.1038/s41591-022-02085-7
State	Published - Jan 2023

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1038/s41591-022-02085-7

Cite this

Vlake, J. H., van Bommel, J., Riva, G., Wiederhold, B. K., Cipresso, P., Rizzo, A. S., Botella, C., Hooft, L., Bienvenu, O. J., Geerts, B., Wils, E. J., Gommers, D., & van Genderen, M. E. (2023). Reporting the early stage clinical evaluation of virtual-reality-based intervention trials: RATE-VR. Nature medicine, 29(1), 12-13. https://doi.org/10.1038/s41591-022-02085-7

@article{f9f8ec5a15fa4336af641624dd23c7f8,

title = "Reporting the early stage clinical evaluation of virtual-reality-based intervention trials: RATE-VR",

author = "Vlake, {Johan H.} and {van Bommel}, Jasper and Giuseppe Riva and Wiederhold, {Brenda K.} and Pietro Cipresso and Rizzo, {Albert Skip} and Cristina Botella and Lotty Hooft and Bienvenu, {O. Joseph} and Bart Geerts and Wils, {Evert Jan} and Diederik Gommers and {van Genderen}, {Michel E.}",

note = "Funding Information: B.G. has received consultancy and research grants from Philips and Edwards Lifesciences, and is owner and board member of Healthplus.ai and its subsidiaries. D.G. has received speaker fees and travel expenses from Dr{\"a}ger, GE Healthcare (medical advisory board 2009–2012), Maquet and Novalung (medical advisory board 2015–2018). All other authors declare no competing interests.",

year = "2023",

month = jan,

doi = "10.1038/s41591-022-02085-7",

language = "English (US)",

volume = "29",

pages = "12--13",

journal = "Nature medicine",

issn = "1078-8956",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Reporting the early stage clinical evaluation of virtual-reality-based intervention trials

T2 - RATE-VR

AU - Vlake, Johan H.

AU - van Bommel, Jasper

AU - Riva, Giuseppe

AU - Wiederhold, Brenda K.

AU - Cipresso, Pietro

AU - Rizzo, Albert Skip

AU - Botella, Cristina

AU - Hooft, Lotty

AU - Bienvenu, O. Joseph

AU - Geerts, Bart

AU - Wils, Evert Jan

AU - Gommers, Diederik

AU - van Genderen, Michel E.

N1 - Funding Information: B.G. has received consultancy and research grants from Philips and Edwards Lifesciences, and is owner and board member of Healthplus.ai and its subsidiaries. D.G. has received speaker fees and travel expenses from Dräger, GE Healthcare (medical advisory board 2009–2012), Maquet and Novalung (medical advisory board 2015–2018). All other authors declare no competing interests.

PY - 2023/1

Y1 - 2023/1

UR - http://www.scopus.com/inward/record.url?scp=85144150116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85144150116&partnerID=8YFLogxK

U2 - 10.1038/s41591-022-02085-7

DO - 10.1038/s41591-022-02085-7

M3 - Letter

C2 - 36526724

AN - SCOPUS:85144150116

SN - 1078-8956

VL - 29

SP - 12

EP - 13

JO - Nature medicine

JF - Nature medicine

IS - 1

ER -

Reporting the early stage clinical evaluation of virtual-reality-based intervention trials: RATE-VR

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this